For Immediate Release

DIA AND AMEIFAC TO HOST 2ND LATIN AMERICAN REGULATORY CONFERENCE
NOVEMBER 18-20 IN MEXICO CITY

HORSHAM, PA, USA—OCTOBER 6, 2009—The Drug Information Association (DIA), in collaboration with the Asociación de Médicos Especialistas en la Industria Farmacéutica (AMEIFAC), will host the bilingual 2nd Latin American Regulatory Conference (November 18-20, 2009; Mexico City, Mexico).

This conference will convene representatives from regulatory authorities, industry, and academia to discuss the current regulatory environment in Latin America, including  in-depth interactive discussion on the benefits, barriers, and direction of harmonization, as well as insight into the regulatory trends across the lifecycle of products. Sessions topics will include:

• Harmonization Initiatives Throughout The Americas

• Current Environment for Regulatory Authorities and Industry for Latin America

• Current Status of Pan American Network for Drug Regulatory Harmonization (PANDRH): Overview and Working Group Updates

• Good Regulatory Practice (GRP): Ensuring Quality Throughout the Regulatory Process

• Collaborative Efforts on Inspections

• Collaborative Efforts on Pharmacovigilance

• Regulatory Updates from Latin American Countries

• Global Clinical Development: Opportunities in Latin America

• Biotechnology Paradigm in Latin America

• Promoting Faster Access by Globalizing Regulatory Processes

“This is the only conference of its kind that brings together regulatory authorities, industry and academic professionals from the U.S and Latin America,” explains Program co-chair Sergio Guerrero, MD, Director, OCA Hospital/Monterrey International Research Center, Mexico. “Conference attendees will receive important updates on harmonized regulatory requirements and how they impact access to medicines and future research and development in the Latin American region.”

Click here to register.

About the Drug Information Association (DIA)
The Drug Information Association (DIA) serves more than 30,000 professionals from regulatory agencies, academia, and the biopharmaceutical industry worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based board of directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

###

Contact: Joe Krasowski
DIA
+1-215-293-5812
Joe.Krasowski@diahome.org

Ellen Diegel
DIA
+1-215-442-6158
Ellen.Diegel@diahome.org